fig1
From: Adjuvant role of a T-type calcium channel blocker, TTA-A2, in lung cancer treatment with paclitaxel
Figure 1. In immunocytochemistry assay, the expression of both Cav3.1 and Cav3.2 was observed in the cells. The no primary antiboday control (A) showed only hematoxylin staining (DAB intensity: 0.273 OD). Cav3.1 antibody-stained cells (B) showed an OD value of 0.349, while Cav3.2 antibody-stained cells (C) showed an OD value of 0.412. Scale bar: 50 μm. OD: Optical density; DAB: 3,3'Diaminobenzidine.
